Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longchuan Bai

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Neoplasia (New York, N.Y.)|April 24, 2022
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-X<sub>L</sub> dual inhibitor that induces Bax-dependent apoptosisWeilong Yao, Longchuan Bai, Shaomeng Wang, et al.
Gastroenterology|September 6, 2006
Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protectionLongchuan Bai, John Y Kao, David J Law, et al.
Cancer Research|January 14, 2012
LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signalingLongchuan Bai, Donna McEachern, Chao-Yie Yang, et al.
The Journal of Biological Chemistry|October 18, 2007
Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89Sergey Chupreta, Holly Brevig, Longchuan Bai, et al.
Journal of Mammary Gland Biology and Neoplasia|October 12, 2012
Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeuticsShaomeng Wang, Longchuan Bai, Jianfeng Lu, et al.
Plos One|June 6, 2014
BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivoLongchuan Bai, Jianfang Chen, Donna McEachern, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitorsCindy Gomez, Longchuan Bai, Jian Zhang, et al.
ACS Medicinal Chemistry Letters|July 3, 2010
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 InhibitorsJianyong Chen, Longchuan Bai, Denzil Bernard, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 InhibitorsRajib Bhuniya, Xinrui Yuan, Longchuan Bai, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 14, 2006
Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defenseJohn Y Kao, Sivaprakash Rathinavelu, Kathryn A Eaton, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Neoplasia (New York, N.Y.)|April 24, 2022
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-X<sub>L</sub> dual inhibitor that induces Bax-dependent apoptosisWeilong Yao, Longchuan Bai, Shaomeng Wang, et al.
Gastroenterology|September 6, 2006
Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protectionLongchuan Bai, John Y Kao, David J Law, et al.
Cancer Research|January 14, 2012
LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signalingLongchuan Bai, Donna McEachern, Chao-Yie Yang, et al.
The Journal of Biological Chemistry|October 18, 2007
Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89Sergey Chupreta, Holly Brevig, Longchuan Bai, et al.
Journal of Mammary Gland Biology and Neoplasia|October 12, 2012
Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeuticsShaomeng Wang, Longchuan Bai, Jianfeng Lu, et al.
Plos One|June 6, 2014
BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivoLongchuan Bai, Jianfang Chen, Donna McEachern, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitorsCindy Gomez, Longchuan Bai, Jian Zhang, et al.
ACS Medicinal Chemistry Letters|July 3, 2010
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 InhibitorsJianyong Chen, Longchuan Bai, Denzil Bernard, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 InhibitorsRajib Bhuniya, Xinrui Yuan, Longchuan Bai, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 14, 2006
Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defenseJohn Y Kao, Sivaprakash Rathinavelu, Kathryn A Eaton, et al.
Pageof 7